Zinc oxide nanoparticles induce toxicity in diffuse large B-cell lymphoma cell line U2932 via activating PINK1/Parkin-mediated mitophagy.

• DOI: 10.1016/j.biopha.2023.114988
• Publication Date: 2023-06-10T20:55:56Z
• Authors: Zonghong Li; Xuewei Yin; Chunyi Lyu; Teng Wang; Wenhao Wang; Jiachen Zhang; Jinxin Wang; Zhenzhen Wang; Chen Han; Ruixue Zhang; Dadong Guo; Ruirong Xu
• Keywords: 0303 health sciences; 03 medical and health sciences; Ubiquitin-Protein Ligases; Mitophagy; Humans; Nanoparticles; Lymphoma, Large B-Cell, Diffuse; Zinc Oxide; Reactive Oxygen Species; Protein Kinases; Mitochondria; Cell Line

Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. Zinc oxide (ZnO) nanoparticles have excellent anti-tumor properties in the biomedical field. The present study aimed to explore the underlying mechanism by which ZnO nanoparticles induce toxicity in DLBCL cells (U2932) via the PINK1/Parkin-mediated mitophagy pathway. After U2932 cells were exposed to various concentrations of ZnO nanoparticles, the cell survival rate, reactive oxygen species (ROS) generation, cell cycle arrest, and changes in the expression of PINK1, Parkin, P62, and LC3 were monitored. Moreover, we investigated monodansylcadaverine (MDC) fluorescence intensity and autophagosome and further validated the results using the autophagy inhibitor 3-methyladenine (3-MA). The results showed that ZnO nanoparticles could effectively inhibit the proliferation of U2932 cells and induce cell cycle arrest at the G0/G1 phases. Moreover, ZnO nanoparticles significantly increased ROS production, MDC fluorescence intensity, autophagosome formation, and the expression of PINK1, Parkin, and LC3, and decreased the expression of P62 in U2932 cells. In contrast, the autophagy level was reduced after the intervention of the 3-MA. Overall, ZnO nanoparticles can trigger PINK1/Parkin-mediated mitophagy signaling in U2932 cells, which may be a potential therapeutic approach for DLBCL.